клинична медицина
3770 проекта
онкология1857кардиология336ендокринология314психиатрия250ембриология236хирургия212физиотерапия149акушерство142пневмология137офталмология122трансплантация119гастроентерология94ангиология69ревматология67алергология60хепатология59нефрология51рентгенология36хематология28интензивна медицина19гинекология19дентална медицина16оториноларингология15ортопедия13
FP7Реинтеграция2013–2017Испания
MIRNATHERAPYNBL · New epigenetic therapy for high-risk neuroblastoma
FP7Реинтеграция2013–2017Турция
MPI-ANGIO · Magnetic Particle Imaging for Safe Angiography
FP7Реинтеграция2013–2017Обединеното кралство
LIVERNCODE · Transcribed-Ultraconserved Regions as novel biomarkers and therapeutic targets in liver cancer
2 партньори
FP7Реинтеграция2013–2017Турция
TRIGBM · Identification of TRAIL sensitivity/resistance mechanisms and searching for novel TRAIL-sensitizing agents in Glioblastoma Multiforme
FP7Реинтеграция2013–2017Нидерландия
BLADDER CANCER EPID · Nutrition and Bladder Cancer
FP7Реинтеграция2013–2017Белгия
METABOLISMCONNECT · Can metabolic states induced by diabetes and obesity promote cancer?
FP7Обмен на изследователи2013–2017Испания
AIDPATH · Academia and Industry Collaboration for Digital Pathology
11 партньори · 8 държави
FP7Реинтеграция2013–2017Германия
VASCAMY · Vascular and Aymloid Predictors of Neurodegeneration and Cognitive Decline in Nondemented Subjects
FP7Реинтеграция2013–2017Франция
LSD1 IMPACT · Dissecting the interaction network of the histone demethylase LSD1 in vivo
FP7Реинтеграция2013–2017Турция
NEURO-VPA · Neural Mechanisms of Visual Perception and Attention
FP7Реинтеграция2013–2017Франция
CORTICAL-ALS · Cortico-Spinal Motor Neurons in Amyotrophic Lateral Sclerosis : Contribution, Mechanisms and Therapy
FP7Реинтеграция2013–2017Франция
PRONO · Notch and epithelial proliferation
FP7Реинтеграция2013–2017Нидерландия
TISSUECONTROLNETWORK · Genetic interaction networks in a self-renewing human tissue
FP7Реинтеграция2013–2017Австрия
MOMECODE · Molecular Mechanisms of Cerebral Cortex Development
FP7Реинтеграция2013–2017Обединеното кралство
SERPLUC · Suppression of Enzymes Required for Progression of LUng Cancer
FP7Реинтеграция2013–2017Португалия
CELLSYNCIRCUITS · CELLULAR AND SYNAPTIC DISSECTION OF THE NEURONAL CIRCUITS OF SOCIAL AND AUTISTIC BEHAVIOR
FP7Реинтеграция2013–2017Израел
SMURF2 IN CANCER · Molecular mechanisms of tumor suppressor functions of HECT-type E3 ligase Smurf2: roles in chromatin organization, dynamics, gene expression and DNA damage response and repair
FP7Реинтеграция2013–2017Испания
GLYCODRUGS · new strategies for controlling the activity of glycosidase enzymes and their application in therapies for lysosomal storage diseases and cancer
FP7Реинтеграция2013–2017Нидерландия
HETODEP · Bringing the field of psychiatry forward: Unraveling heterogeneity of Depression
2 партньори
FP7Индивидуална стипендия2013–2015Швеция
NCAT · Nudix hydrolases in Cancer Therapy
FP7Индивидуална стипендия2013–2015Белгия
ADJSYN · Understanding how immunostimulant combinations in adjuvants synergise to enhance vaccine responses
FP7Индивидуална стипендия2013–2015непознат регион
LUNG INFLAMMATION · An investigation into the differential mechanisms and regulation of leukocyte clearance from the human lung across two distinct barriers: the bronchial epithelium versus the alveolar epithelium
FP7Индивидуална стипендия2013–2015Обединеното кралство
ImageMelTherapyLRI · Single cell level intravital imaging of response, tolerance, and resistance to targeted therapies
2 партньори
FP7Индивидуална стипендия2013–2015Белгия